Evidence map›Paper›PMID 41798135›Full record

ArticleNeuro-oncology practice2026

High-grade gliomas and Lynch syndrome: A retrospective descriptive study with a literature review.

Hugo Duprez, Apolline Monfilliette, Marie Csanyi, Claude-Alain Maurage, Fabienne Escande, Afane Brahimi, Anthony Turpin, Nicolas Reyns, Luc Defebvre, Enora Vauleon

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hugo DuprezDepartment of Neuro Oncology, CHU Lille, 59000 Lille, France.ORCID https://orcid.org/0009-0007-4997-813X
Apolline MonfillietteDepartment of Neuro Oncology, CHU Lille, 59000 Lille, France.
Marie CsanyiInstitute of Pathology, CHU Lille, 59000 Lille, France.
Claude-Alain MaurageInstitute of Pathology, CHU Lille, 59000 Lille, France.
Fabienne EscandeDepartment of Biochemistry and Molecular Biology, CHU Lille, 59000 Lille, France.
Afane BrahimiDepartment of Clinical Genetics, CHU Lille, 59000 Lille, France.
Anthony TurpinDepartment of Medical Oncology, CHU Lille, 59000 Lille, France.
Nicolas ReynsDepartment of Neurosurgery, CHU Lille, 59000 Lille, France.
Luc DefebvreDepartment of Neuro Oncology, CHU Lille, 59000 Lille, France.
Enora VauleonDepartment of Neuro Oncology, CHU Lille, 59000 Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-grade diffuse gliomas in adults are common malignant primary tumors of the central nervous system. The association with Lynch syndrome (LS) is documented but remains under-researched. However, there are implications for prevention, genetic counseling, and therapeutic approaches. The objective of this study is to conduct a descriptive cohort of patients with high-grade glial tumors in the context of LS. Methods: We included adult patients with glioblastoma (GBM) or grade 4 astrocytoma (WHO 2021 classification) associated with LS, diagnosed at Lille University Hospital or Valenciennes Hospital between 2014 and 2022. We retrospectively collected clinical, radiological, histopathological, molecular, and therapeutic data. Results: We included 6 GBM cases with a median age of 58.7 years (IQR 32.4-63.3). Five cases had Conclusions: GBMs associated with LS exhibit specific histopathological and molecular biology characteristics that may guide syndrome-related research. These tumors could represent a particular subclassification, potentially leading to specific therapies such as immunotherapy. We propose with a review of case in the literature an algorithm for investigating LS upon discovering a GBM. These exploratory results need to be confirmed by a larger cohort.

Indexed as

glioblastomagliomaLynch syndromeMMR

Identifiers

PMID41798135
PMCPMC12965644

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.